| Nov 13 |
Vivani Medical GAAP EPS of -$0.11
|
| Nov 13 |
Vivani Medical: Q3 Earnings Snapshot
|
| Nov 13 |
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results
|
| Oct 29 |
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now
|
| Oct 22 |
3 US Penny Stocks To Monitor In October 2024
|
| Oct 22 |
Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024
|
| Sep 27 |
Vivani Medical obtains Australian approval to begin GLP-1 implant trial
|
| Sep 26 |
Vivani Medical to Test Implant in Obese and Overweight Patients
|
| Sep 26 |
Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
|
| Sep 26 |
EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia
|
